The Infraredx Makoto Intravascular Ultrasound System brings advanced imaging tools to doctors and nurses in a cath lab. It brings a practical and easy-to-use approach to simplify interaction and communication during a procedure.
Infraredx. “IVUS+NIRS technology has the potential to dramatically change the field of interventional cardiology. Two unique modalities in one catheter provide cardiologists twice the information of other imaging catheters, helping to inform personalized treatment decisions.
The design wraps InfraRedX’s advanced technology in an aesthetically pleasing and easy-to-use form to produce a solution that brings life saving technology to hospitals around the globe. By simplifying the details and focusing on the user, the Makoto Intravascular Ultrasound System provides real value that benefits patients, caregivers and InfraRedX alike.
The Makoto™ Intravascular Imaging System, with accompanying Dualpro™ IVUS+NIRS Catheter, is the only imaging system on the market today that utilizes not just intravascular ultrasound (IVUS) but also Near-Infrared Spectroscopy (NIRS) to help clinicians visualize vessel structure and gain valuable insights into plaque composition. Our revolutionary technology is the only FDA-cleared imaging technology indicated for the detection of Lipid Core Plaque (LCP).
The Makoto Intravascular Imaging System and Dualpro catheter is the only technology on the market to identify vessel structure and plaque composition using IVUS+NIRS. Its launch follows market approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) in August 2017.
Dualpro is the only imaging catheter on the market equipped with extended bandwidth IVUS technology. By emitting and carefully processing a broad band of frequencies, the Dualpro IVUS provides best-in-class image resolution without compromising depth of field. Data collected from the NIRS technology are translated into a Chemogram, an easy-to-interpret, color-coded map to identify lipid core plaque (LCP), which can help distinguish between stable plaque and dangerous LCP. Coupled together, IVUS+NIRS arms cardiologists with unparalleled insights into the role LCP plays in heart disease.
There are several global landmark studies, including the Lipid-Rich Plaque (LRP) Study, currently underway, which underscore the importance of identifying LCP for the prediction, and ultimately prevention, of serious heart attacks. Results of the prospective, multi-center LRP Study, along with a U.S. market launch of the Makoto Imaging System and Dualpro IVUS+NIRS catheter, are anticipated in 2H 2018. The technology is currently the only FDA-cleared dual-modality catheter and imaging system indicated for the detection of LCP.
About the Makoto Intravascular Imaging System
The Makoto Intravascular Imaging System, with accompanying Dualpro™ IVUS+NIRS catheter, is the only technology on the market to identify vessel structure and plaque composition using IVUS+NIRS. Combining best-in-class image resolution with insight into the composition of plaque via Chemogram, IVUS+NIRS provides cardiologists with the tools needed to potentially predict, and ultimately prevent serious heart attacks.
Price is set at $21,400
We ship to all locations and we are very ready to serve you, For purchase
and inquiries, Message GoldenMed Hospitech today via email @
plus you can text us at +16468911806
Visit our website at https://goldenmedhospitechus.wordpress.com/ or email us Goldenmedhospitech@usa.com
so we can best assist you.
We also have both new and refurbished ones in excellent shape, we’re certain that it works for you